Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) EBT (2011 - 2026)

Emergent BioSolutions (EBS) posted EBT of -$166.3 million for Q2 2026, down 1341.04% on a QoQ basis from $13.4 million in Q1 2026, and down 889.88% year-over-year from $21.1 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) EBT (2011 - 2026) Analysis & Trends

Emergent BioSolutions has reported EBT for 16 years, with the latest figure at -$166.3 million in Q2 2026.

  • On a quarterly basis, EBT fell 889.88% year-over-year to -$166.3 million in Q2 2026; TTM through Jun 2026 was -$146.0 million, a 176.56% decrease from a year earlier, with the FY2025 full-year figure at $82.8 million, up 157.94% from the prior year.
  • EBT was -$166.3 million for Q2 2026 at Emergent BioSolutions, down from $13.4 million in the prior quarter.
  • The five-year high for EBT was $142.4 million in Q3 2024, with the low at -$269.8 million in Q2 2024.
  • Average EBT over 5 years is -$64.4 million, with a median of -$52.6 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2025: EBT slumped 4126.32% in 2023, then soared 666.12% in 2025.
  • Over 5 years, EBT stood at -$61.4 million in 2022, then climbed by 11.24% to -$54.5 million in 2023, then soared by 49.36% to -$27.6 million in 2024, then slumped by 83.7% to -$50.7 million in 2025, then sank by 228.01% to -$166.3 million in 2026.
  • The last three EBT figures came in at -$166.3 million (Q2 2026), $13.4 million (Q1 2026), and -$50.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 6.75 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 4.28 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 4.27 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn -653.00 Mn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 4.09 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 1.64 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 312.46 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - -644.37 Mn
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -166.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -166.30 Mn
Mar 31, 2026 13.40 Mn
Dec 31, 2025 -50.70 Mn
Sep 30, 2025 57.60 Mn
Jun 30, 2025 -16.80 Mn
Mar 31, 2025 92.70 Mn
Dec 31, 2024 -27.60 Mn
Sep 30, 2024 142.40 Mn
Jun 30, 2024 -269.80 Mn
Mar 31, 2024 12.10 Mn
Dec 31, 2023 -54.50 Mn
Sep 30, 2023 -265.90 Mn
Jun 30, 2023 -250.20 Mn
Mar 31, 2023 -160.60 Mn
Dec 31, 2022 -61.40 Mn
Sep 30, 2022 -67.20 Mn
Jun 30, 2022 -82.80 Mn
Mar 31, 2022 -3.80 Mn
Dec 31, 2021 256.30 Mn
Sep 30, 2021 -45.50 Mn
API Access

Emergent BioSolutions EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=EBS&period=max&api_key=YOUR_API_KEY